{"disease":{"id":"vulnerable-coronary-plaques","name":"vulnerable coronary plaques"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06855537","title":"Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2190,"lead_sponsor_name":"Beijing Anzhen Hospital","has_results":false},{"nct_id":"NCT04680689","title":"Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Cardio Med Medical Center","has_results":false},{"nct_id":"NCT04397198","title":"The Assessment Of Myocardial Viability Based On CTA/MRI Hybrid Models","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Cardio Med Medical Center","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}